Labcorp will offer the FDA-cleared Elecsys® pTau217 test, supporting a more consistent approach to assessing amyloid pathology associated with Alzheimer’s disease across care settings.
Learn more: bit.ly/4cXZiOZ
#AlzheimersDisease #Neurology #Diagnostics
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly #InPursuitOfAnswers.

